Literature DB >> 10449074

Transverse cervical artery bypass pedicle for treatment of common carotid artery occlusion: new adjunct for revascularization of the internal carotid artery domain.

T Kobayashi1, K Houkin, F Ito, Y Kohama.   

Abstract

OBJECTIVE: We present two cases of common carotid artery occlusion that were treated by vascular reconstruction using the transverse cervical artery.
METHODS: Two patients with common carotid artery occlusion presented with transient ischemic attacks resulting from decreased cerebral blood flow on the affected side. Both patients underwent vascular reconstruction using the transverse cervical artery. The transverse cervical artery was anastomosed to the ipsilateral external carotid artery at its origin, as a pedicle graft. A superficial temporal artery-middle cerebral artery anastomosis was then performed.
RESULTS: The postoperative courses were uneventful. The transverse cervical artery bypass grafts were patent, and cerebral blood flow increased to normal levels.
CONCLUSION: Transverse cervical artery grafting provides a less tedious alternative to saphenous vein interposition grafting for revascularization of the internal carotid artery domain.

Entities:  

Mesh:

Year:  1999        PMID: 10449074     DOI: 10.1097/00006123-199908000-00020

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Common Carotid Artery Occlusion: A Single-Center Experience in 40 Cases.

Authors:  Sergio Belczak; Grace Carvajal Mulatti; Sergio Ricardo Abrão; Erasmo Simão da Silva; Ricardo Aun; Pedro Puech-Leão; Nelson de Luccia
Journal:  Int J Angiol       Date:  2015-03-23

2.  Common trunk of the internal thoracic artery, inferior thyroid artery and thyrocervical trunk from the subclavian artery: a rare arterial variant.

Authors:  Karolina Westrych; Kacper Ruzik; Nicol Zielinska; Friedrich Paulsen; Georgi P Georgiev; Łukasz Olewnik; Piotr Łabętowicz
Journal:  Surg Radiol Anat       Date:  2022-07-06       Impact factor: 1.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.